-
Mc-Val-Cit-PABC-PNP Product Overview
2026-10-10
Mc-Val-Cit-PABC-PNP (SKU B1003) is described by APExBIO as a cathepsin cleavable ADC peptide linker for antibody-drug conjugate research. No matched paper evidence was provided, so performance, mechanism, and therapeutic applicability cannot be independently assessed here.
-
AZD8055: Product Identity and Evidence Limits
2026-10-09
AZD8055 is an APExBIO-listed research compound described as an ATP-competitive mTOR inhibitor. With no matched paper evidence available here, its reported selectivity, biological activity, and research applicability cannot be independently evaluated.
-
Pitavastatin (NK-104): Product Overview
2026-10-09
Pitavastatin, also identified as NK-104 and SKU B1124, is an APExBIO-listed HMG-CoA reductase inhibitor for conceptual cholesterol-biosynthesis and cardiovascular research contexts. No directly matched paper evidence is available in the supplied dossier.
-
Bufalin–CRISPR Nanomedicine for Colorectal Cancer
2026-10-08
Liu et al. report a calcium lactate nanoparticle system that co-delivers bufalin and a CD47-targeting CRISPR/Cas9 ribonucleoprotein to coordinate tumor-cell death with macrophage-mediated immunity. The preclinical findings support a multimodal strategy involving pyroptosis, apoptosis, M1-like macrophage reprogramming, and enhanced phagocytosis, while leaving important questions about safety, editing specificity, biodistribution, and clinical translation unresolved.
-
PERK-Dependent Pyroptosis in Disc Degeneration
2026-10-07
The reference study links unresolved endoplasmic reticulum stress to nucleus pulposus cell pyroptosis through a PERK/eIF2α/ATF4–JAK1–STAT3 signaling axis. Its cell-based evidence clarifies a possible connection between unfolded protein response activity and inflammatory cell death, while also showing why pharmacological follow-up must be distinguished from the genetic perturbations used in the paper.
-
Linoleic Acid (C18:2): Product Overview
2026-10-07
Linoleic Acid, also identified as C18:2(9Z,12Z), is a C18H32O2 omega-6 fatty acid listed by APExBIO for conceptual research involving lipid biology, membranes, and oxidative processes. No matched paper evidence was provided, so product-specific performance and application claims remain unverified.
-
Diethylmaleate in Redox and GST Research
2026-10-06
Diethylmaleate is widely used as a redox-modulating research compound, but the strongest supplied evidence concerns GST-linked insecticide resistance in Megalurothrips usitatus. This overview separates reported findings from interpretation, compares evidence strength, and defines limits for cell, toxicology, and reproductive oxidative-stress research.
-
Romidepsin: Reading Epigenetic Evidence in Cancer
2026-10-05
Romidepsin and FK228 are selective class I HDAC inhibitors used to study chromatin regulation, apoptosis, and cell-cycle control. This article explains how to interpret Romidepsin evidence alongside a multidimensional proteomics study of Platycodin D, while separating direct target evidence from downstream pathway associations.
-
Doxorubicin in 3D Tumor Models: Reading Resistance
2026-10-05
Doxorubicin and Adriamycin remain valuable mechanistic benchmarks, but 3D tumor models can change how their apparent potency and resistance are interpreted. This evidence-focused analysis connects doxorubicin biology with collagen microtissues, hypoxia, cellular state, and translational model validity.
-
TRPV1+ Nerves and the Somato-Autonomic Reflex
2026-10-04
Song et al. report that stimulating TRPV1-positive peripheral sensory nerves can suppress systemic inflammation through coordinated brainstem, endocrine, autonomic, and splenic responses. The study’s main contribution is a mechanistic neuroimmune framework, while its animal-model evidence should be interpreted cautiously when considering other inflammatory systems or translational applications.
-
Amplex Red Assay for Autotaxin Inhibitor Profiling
2026-10-03
Stylianaki et al. present a standardized, fluorescence-based microplate assay for detecting and characterizing autotaxin inhibitors. The protocol extends beyond initial hit identification by incorporating IC50 analysis, false-positive assessment, and enzyme-kinetic interpretation, while remaining limited to biochemical in vitro evidence.
-
GST-Mediated Lambda-Cyhalothrin Resistance in M. usitatus
2026-10-02
This 2024 study shows that glutathione S-transferase (GST) strengthens antioxidant defenses in Megalurothrips usitatus exposed to lambda-cyhalothrin, linking GST activity with insecticide resistance. By combining RT-qPCR, biochemical measurements, apoptosis-related markers, and diethyl maleate-mediated GST inhibition, the authors provide functional evidence that redox protection contributes to the resistant phenotype.
-
GST-Mediated Lambda-Cyhalothrin Resistance
2026-10-01
Dong and colleagues show that glutathione S-transferase (GST) supports Megalurothrips usitatus resistance to lambda-cyhalothrin by reinforcing antioxidant defenses, not only by contributing to xenobiotic detoxification. Inhibition with diethyl maleate reduced GST activity, weakened antioxidant capacity, and markedly increased insecticide sensitivity, providing a mechanistic framework for resistance research and redox-focused assay design.
-
Calcitriol at the Bone–Immune Interface
2026-10-01
Calcitriol, or 1,25-dihydroxy vitamin D3, can serve as a mechanistic perturbation tool for studying coupled osteoblast–osteoclast biology. This article connects vitamin D receptor signaling with the NFIA–RANKL–SFRP1 framework and provides practical guidance for designing interpretable bone homeostasis assays.
-
EZ Cap™ SaCas9 mRNA in Functional Genomics
2026-09-30
EZ Cap™ SaCas9 mRNA supports transient, programmable genome editing for vertebrate functional genomics. This guide explains its mechanism, assay-design logic, validation strategy, and the practical trade-offs that distinguish mRNA delivery from DNA, RNP, and precision-editing workflows.